In this podcast, experts discuss what people with early-stage lung cancer should know about molecular testing, including what it is, how it may be used in guiding treatment decisions, and several recent studies about its role in treatment planning. Read More >>
targeted therapy
June 15, 2022 · Brielle Gregory Collins, ASCO staff
June 9, 2022 · H. Jack West, MD
Dr. H. Jack West shares what people with lung cancer should know about biomarker testing, including why it is important in planning treatment and what to expect during the testing process. Read More >>
June 6, 2022 · Brielle Gregory Collins, ASCO staff
The ASCO Annual Meeting is being held June 3 to 7, and here is some of the notable research that will be presented today. Today’s research includes a study on a targeted therapy combination for treating low-grade childhood glioma with a BRAF V600 mutation. Read More >>
June 5, 2022 · Leslie Fannon Zhang, ASCO staff
The ASCO Annual Meeting is being held June 3 to 7, and here is some of the notable research that will be presented today. Topics include advances in treating HER2-low metastatic breast cancer, RAS wild-type metastatic colorectal cancer, recurrent and refractory Ewing sarcoma, and newly diagnosed multiple myeloma. Read More >>
June 4, 2022 · Brielle Gregory Collins, ASCO staff
The ASCO Annual Meeting is being held June 3 to 7, and here is some of the notable research that will be presented today. Topics include targeted therapy for advanced hormone receptor-positive, HER2-negative breast cancer and using liquid biopsy to guide post-surgery treatment decisions for stage II colon cancer. Read More >>